Security Snapshot

Nuvation Bio Inc. - Common Stock (NUVB) Institutional Ownership

CUSIP: 67080N101

13F Institutional Holders and Ownership History from Q1 2021 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

194

Shares (Excl. Options)

146.43MFull value: 146,433,406 · shares · 30 Sep 2026

Price

$5.60

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.01%
Share change
+10,766,830
Value change
+$58,766,592
Number of holders
194
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
339,200,672
SEC-reported price per share
$4.70
Insider filing price
$4.70
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • NUVB - Nuvation Bio Inc. - Common Stock is tracked under CUSIP 67080N101.
  • 194 institutions reported positions in Q3 2026.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 242 to 194 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $1.33BFull value: $1,325,260,573 · USD · 30 Jun 2026
    to
    $818.46MFull value: $818,462,687 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 194 institutions filings for Q3 2026.

Open SEC evidence

Security key

67080N101

13F reference period

Q3 2026

13F holders

194

13D/G owners

2

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
2
Security
NUVB
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 15% +11% $110,306,310 +$11,583,764 50,599,225 +12% FMR LLC 31 Mar 2025
BlackRock, Inc. 6.4% +30% $42,332,244 +$10,273,842 21,708,843 +32% BlackRock, Inc. 30 Jun 2025
As of 30 Sep 2026, 194 institutional investors reported holding
146.43MFull value: 146,433,406 · shares · 30 Sep 2026
shares of Nuvation Bio Inc. - Common Stock (NUVB). This represents 43% of the company’s total
339.2MFull value: 339,200,672 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
32%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Decheng Capital LLC 7.7% 25,954,439 21% $145,344,858
VANGUARD CAPITAL MANAGEMENT LLC 3.6% 12,152,903 0% $68,056,257
Laurion Capital Management LP 2.3% 7,697,272 3.3% $43,104,723
STATE STREET CORP 2.2% 7,596,209 0% $42,538,770
Omega Fund Management, LLC 2.1% 7,151,031 32% $40,045,774
GEODE CAPITAL MANAGEMENT, LLC 1.9% 6,446,677 0% $36,108,860
GOLDMAN SACHS GROUP INC 1.3% 4,511,958 0% $25,266,965
Jones Hill Capital LP 1.3% 4,486,986 4.3% $25,127,122
TWO SIGMA INVESTMENTS, LP 0.97% 3,300,303 0.01% $18,481,697
TANG CAPITAL MANAGEMENT LLC 0.97% 3,299,557 0.85% $18,477,519
Redmile Group, LLC 0.89% 3,031,009 1.2% $16,973,650
VANGUARD PORTFOLIO MANAGEMENT LLC 0.77% 2,619,082 0% $14,666,859
Connor, Clark & Lunn Investment Management Ltd. 0.75% 2,536,908 0.02% $14,206,685
Duquesne Family Office LLC 0.67% 2,269,900 0.31% $12,711,000
ARMISTICE CAPITAL, LLC 0.62% 2,096,000 0.39% $11,737,600
VANGUARD FIDUCIARY TRUST CO 0.55% 1,879,786 0% $10,526,802
DIMENSIONAL FUND ADVISORS LP 0.54% 1,825,240 0% $10,221,344
Knoll Capital Management, LLC 0.47% 1,598,591 4.3% $8,952,109
NewEdge Advisors, LLC 0.46% 1,546,883 0.03% $8,662,545
ESSEX INVESTMENT MANAGEMENT CO LLC 0.4% 1,344,871 1.1% $7,531,278
RENAISSANCE TECHNOLOGIES LLC 0.39% 1,319,695 0.01% $7,390,292
Invesco Ltd. 0.38% 1,289,247 0% $7,219,783
BANK OF AMERICA CORP /DE/ 0.38% 1,273,763 0% $7,133,073
ABRAMS CAPITAL MANAGEMENT, L.P. 0.37% 1,270,504 0.15% $7,114,822
Woodline Partners LP 0.36% 1,235,854 0.02% $6,920,782

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
23
Headline period
Q3 2026
Rows shown
1-23 of 23
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 146,433,406 $818,462,687 +$58,766,592 $5.60 194
2026 Q2 233,386,890 $1,325,260,573 +$84,358,811 $5.68 242
2026 Q1 220,379,317 $945,297,446 -$2,153,589 $4.29 230
2025 Q4 211,333,629 $1,893,184,000 -$57,998,580 $8.96 223
2025 Q3 220,537,335 $817,798,856 -$1,495,817 $3.70 201
2025 Q2 224,729,650 $439,155,420 +$34,613,471 $1.95 179
2025 Q1 207,335,118 $364,911,263 +$18,852,443 $1.76 159
2024 Q4 197,748,566 $526,027,669 +$38,581,638 $2.66 159
2024 Q3 187,137,100 $428,593,958 +$73,128,321 $2.29 153
2024 Q2 153,048,262 $446,948,909 +$52,594,408 $2.92 146
2024 Q1 134,652,746 $490,113,918 +$5,142,866 $3.64 122
2023 Q4 134,270,272 $202,718,680 -$2,287,216 $1.51 116
2023 Q3 136,892,011 $183,439,434 -$9,239,486 $1.34 122
2023 Q2 139,011,387 $250,194,724 +$3,219,600 $1.80 120
2023 Q1 137,479,282 $228,214,660 -$4,709,474 $1.66 126
2022 Q4 139,580,600 $267,992,788 -$12,224,298 $1.92 123
2022 Q3 141,780,239 $317,588,133 -$44,323,294 $2.24 116
2022 Q2 155,298,098 $503,167,223 -$21,514,875 $3.24 116
2022 Q1 159,104,350 $836,898,347 +$14,198,236 $5.26 112
2021 Q4 155,258,449 $1,319,350,594 +$21,011,876 $8.50 103
2021 Q3 151,280,175 $1,503,381,648 +$33,688,697 $9.94 97
2021 Q2 147,981,823 $1,364,632,796 +$15,849,184 $9.31 97
2021 Q1 145,559,447 $1,478,100,000 +$1,473,836,329 $10.45 72
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .